Narcolepsy: why you’ve been thinking about it all wrong
Summary
This episode of Science Weekly corrects common misconceptions about narcolepsy and explores the recent FDA approval of a first-of-its-kind orexin agonist drug. Host Ian Sample discusses the condition’s true symptoms, including cataplexy and excessive daytime sleepiness, with guest Maddy and patient Julie Flyger. They explain the underlying biology involving the loss of orexin-producing neurons, likely due to an autoimmune response, and how the new therapy targets this root cause rather than just managing symptoms. The conversation highlights the significant quality-of-life improvements repo…
Topics discussed
Sponsor: Quo business phone system
Sponsor: Washington Wise from Charles Schwab
Introduction: Narcolepsy myths and new drug
Explaining narcolepsy symptoms and types
Personal story: Julie Flyger's sleep paralysis
Understanding cataplexy and muscle weakness
Daily life impact and driving challenges
Current treatments and their limitations
Discovery of orexin and narcolepsy biology
How orexin regulates sleep-wake cycles
The new orexin agonist drug and FDA approval
Patient reactions and global impact
Sponsor: Radical Thinking from The Guardian
Sponsor: Washington Wise from Charles Schwab
Future research and unanswered questions
Conclusion and credits
Recommendation: Slime mold audio long read
Sponsor: Thomson Reuters
Sponsor: Washington Wise from Charles Schwab
Sponsor: Rinse laundry service
Listen ad-free on Castria